site stats

Jounce stock price

NettetJounce Therapeutics Inc (JNCE) NASDAQ Add to Watchlist 1.890 -0.010 ( -0.53 %) 06/04 - Closed. Currency in USD ( Disclaimer) After Hours 1.890 0.000 ( 0.00 %) 06/04 - Real-time Data Volume:... Nettet102 rader · 30. mar. 2024 · Discover historical prices for JNCE stock on Yahoo Finance. View daily, weekly or monthly format back to when Jounce Therapeutics, Inc. stock …

Jounce Therapeutics Inc. (JNCE): Investors are paying attention to …

Nettet15. mar. 2024 · News Jounce Therapeutics Inc. Significant News Only No significant news for JNCE in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-0.99 Market Cap $96.46 M Shares... NettetFollowing a buyout offer from Concentra Biosciences, Jounce’s stock price surged over 20% in Monday’s trading session. The acquisition deal proposed that Concentra would acquire Jounce for $1.85 per share, along with a non-tradeable contingent value right. couch creek california https://hypnauticyacht.com

Jounce Therapeutics, Inc. Common Stock (JNCE) Stock …

Nettet10. apr. 2024 · Jounce Therapeutics recently entered into an agreement to be acquired by Concentra Biosciences for $1.85 in cash per share plus a non-tradeable contingent value right. The offer price... Nettet5. apr. 2024 · Jounce Therapeutics (JNCE) Stock Price & Analysis 302 Followers JNCE Stock Chart & Stats Advanced Chart > Day’s Range $0 - $0 52-Week Range $0.58 - $7.94 Previous Close $1.85 Volume 5.37M Average Volume (3M) 2.75M Market Cap $96.46M Enterprise Value $96.46M Total Cash (Recent Filing) $0.00 Total Debt (Recent Filing) … Nettet7. mar. 2024 · Jounce Therapeutics Inc. (NASDAQ:JNCE) traded at $1.06 at last check on Tuesday, March 07, made a downward move of -1.85% on its previous day’s price. Looking at the stock we see that its previous close was $1.08 and the beta (5Y monthly) reads 0.65 with the day’s price range being $1.01 bred pessac

Jounce Therapeutics (NASDAQ:JNCE) Coverage Initiated by …

Category:Jounce Therapeutics PE Ratio 2015-2024 JNCE MacroTrends

Tags:Jounce stock price

Jounce stock price

Jounce Therapeutics Inc. (NASDAQ: JNCE) Jumps 1.07%: The Most …

Nettet9. apr. 2024 · The stock was sold at an average price of $1.10, for a total transaction of $22,210.10. Jounce Therapeutics Stock Down 0.5 % NASDAQ:JNCE opened at $1.89 on Friday. Nettet27. mar. 2024 · JOUNCE THERAPEUTICS, INC. (Name of Person (s) Filing Statement) Common Stock, $0.001 par value per share (Title of Class of Securities) 481116101 (CUSIP Number of Common Stock) Jacquelyn...

Jounce stock price

Did you know?

NettetJounce Therapeutics (JNCE) is set to be acquired by Concentra Biosciences, spurning an all-share merger deal with British biotech firm Redx Pharma. CRSP : 45.40 (+1.34%) JNCE : 1.8900 (-0.53%) CERT : 23.01 (+0.52%) EQRX : 1.8900 (+2.72%) SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVT, USX, JNCE … Nettet31. mar. 2024 · Complete Jounce Therapeutics Inc. stock information by Barron's. View real-time JNCE stock price and news, along with industry-best analysis.

Nettet6. apr. 2024 · JNCE - Jounce Therapeutics Inc Stock Price Quote - NASDAQ Morningstar Jounce Therapeutics Inc JNCE Stock Quote Morningstar Rating Rating as of Mar 31, 2024 Quote Chart Stock... NettetJounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T ...

Nettet14. apr. 2024 · Five investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat, Jounce Therapeutics presently has an average rating of "Hold" and a consensus target price of $6.00. Jounce Therapeutics Price Performance. Shares of NASDAQ:JNCE opened at … Nettet12. apr. 2024 · According to analysts' consensus price target of $6.00, Jounce Therapeutics has a forecasted upside of 298.7% from its current price of $1.51. …

NettetJounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights March 27, 2024TipRanks. …

Nettet2. feb. 2024 · Jounce Therapeutics Inc (JNCE) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. 🚀 Enjoy a 7-Day Free Trial Thru Apr 09, 2024! Sign Up bred pitchNettet10. apr. 2024 · Jounce Therapeutics stock bounces after saying only 1.4% of its cash was in an SVB operating account. Shares of Jounce Therapeutics Inc. JNCE, -6.09% … bred peopleNettet6. apr. 2024 · See the latest Jounce Therapeutics Inc stock price (NASDAQ:JNCE), related news, valuation, dividends and more to help you make your investing decisions. bred plainteNettetJounce Therapeutics Inc Follow Share $1.61 After Hours: $1.65 (2.48%) +0.040 Closed: Mar 17, 7:54:00 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to Loyalty … couch crashers websiteNettetOn average, Wall Street analysts predict. that Jounce Therapeutics's share price could reach $4.00 by Jan 3, 2024. The average Jounce Therapeutics stock price prediction forecasts a potential upside of 116.22% from the current JNCE share price of $1.85. © bred pince ventNettetJNCE: Get the latest Jounce Therapeutics stock price and detailed information including JNCE news, ... According to the current price, Jounce Therapeutics is 23.05% away … bred paris 19Nettet27. mar. 2024 · Pursuant and subject to the terms of the merger agreement, a subsidiary of Concentra will commence a tender offer by April 7, 2024 to acquire all outstanding shares of Jounce for $1.85 in cash per ... bred place st jean